Show simple item record

dc.contributor.authorWu, Joy T.
dc.contributor.authorde la Hoz, Miguel Á. A.
dc.contributor.authorKuo, Po-Chih
dc.contributor.authorPaguio, Joseph A.
dc.contributor.authorYao, Jasper S.
dc.contributor.authorDee, Edward C.
dc.contributor.authorYeung, Wesley
dc.contributor.authorJurado, Jerry
dc.contributor.authorMoulick, Achintya
dc.contributor.authorMilazzo, Carmelo
dc.contributor.authorPeinado, Paloma
dc.contributor.authorVillares, Paula
dc.contributor.authorCubillo, Antonio
dc.contributor.authorVarona, José F.
dc.contributor.authorLee, Hyung-Chul
dc.contributor.authorEstirado, Alberto
dc.date.accessioned2022-07-11T15:23:33Z
dc.date.available2022-07-11T15:23:33Z
dc.date.issued2022-07-05
dc.identifier.urihttps://hdl.handle.net/1721.1/143642
dc.description.abstractAbstract The unprecedented global crisis brought about by the COVID-19 pandemic has sparked numerous efforts to create predictive models for the detection and prognostication of SARS-CoV-2 infections with the goal of helping health systems allocate resources. Machine learning models, in particular, hold promise for their ability to leverage patient clinical information and medical images for prediction. However, most of the published COVID-19 prediction models thus far have little clinical utility due to methodological flaws and lack of appropriate validation. In this paper, we describe our methodology to develop and validate multi-modal models for COVID-19 mortality prediction using multi-center patient data. The models for COVID-19 mortality prediction were developed using retrospective data from Madrid, Spain (N = 2547) and were externally validated in patient cohorts from a community hospital in New Jersey, USA (N = 242) and an academic center in Seoul, Republic of Korea (N = 336). The models we developed performed differently across various clinical settings, underscoring the need for a guided strategy when employing machine learning for clinical decision-making. We demonstrated that using features from both the structured electronic health records and chest X-ray imaging data resulted in better 30-day mortality prediction performance across all three datasets (areas under the receiver operating characteristic curves: 0.85 (95% confidence interval: 0.83–0.87), 0.76 (0.70–0.82), and 0.95 (0.92–0.98)). We discuss the rationale for the decisions made at every step in developing the models and have made our code available to the research community. We employed the best machine learning practices for clinical model development. Our goal is to create a toolkit that would assist investigators and organizations in building multi-modal models for prediction, classification, and/or optimization.en_US
dc.publisherSpringer International Publishingen_US
dc.relation.isversionofhttps://doi.org/10.1007/s10278-022-00674-zen_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceSpringer International Publishingen_US
dc.titleDeveloping and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Studyen_US
dc.typeArticleen_US
dc.identifier.citationWu, Joy T., de la Hoz, Miguel Á. A., Kuo, Po-Chih, Paguio, Joseph A., Yao, Jasper S. et al. 2022. "Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study."
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Science
dc.identifier.mitlicensePUBLISHER_CC
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2022-07-10T03:21:47Z
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dspace.embargo.termsN
dspace.date.submission2022-07-10T03:21:47Z
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work and Publication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record